Literature DB >> 2791491

Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.

H C Neu1, G Saha, N X Chin.   

Abstract

We examined the susceptibility of 50 isolates of Xanthomonas maltophilia and the effect of beta-lactamase inhibitors upon the susceptibility. The majority of isolates were resistant to azlocillin, piperacillin, mezlocillin, ticarcillin, cefotaxime, ceftizoxime, ceftriaxone, cefoperazone, and ceftazidime. All isolates were resistant to imipenem, CGP 31608, aztreonam, and carumonam. Although disk susceptibility tests showed that the combination of clavulanate with ticarcillin inhibited many isolates, at a ratio of 1:20 few isolates were susceptible to the combination. Addition of clavulanate to aztreonam and to imipenem failed to make organisms susceptible. Sulbactam combined with cefoperazone made some organisms susceptible, but ampicillin-sulbactam was ineffective, whereas tazobactam combined with piperacillin at a ratio of 1:4 made half the isolates have MICs of 32 micrograms/ml or less. The beta-lactamases from the isolates hydrolyzed all of the beta-lactams.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791491     DOI: 10.1016/0732-8893(89)90030-8

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.

Authors:  S Vartivarian; E Anaissie; G Bodey; H Sprigg; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 2.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia.

Authors:  J L Muñoz; M I García; S Muñoz; S Leal; M Fajardo; J A Garćia-Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

4.  Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia.

Authors:  J D Yao; M Louie; L Louie; J Goodfellow; A E Simor
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia.

Authors:  R Paton; R S Miles; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.

Authors:  F Karpati; A S Malmborg; H Alfredsson; L Hjelte; B Strandvik
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

7.  Stenotrophomonas maltophilia infection in patients receiving continuous ambulatory peritoneal dialysis.

Authors:  Joo-Eun Baek; Eun-Young Jung; Hyun-Jung Kim; Gyeong-Won Lee; Jong-Ryeal Hahm; Kee-Ryeon Kang; Se-Ho Chang
Journal:  Korean J Intern Med       Date:  2004-06       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.